Epirubicin in the treatment of malignant mesothelioma: a phase II cooperative study. The North-Eastern Italian Oncology Group (GOCCNE)--Mesothelioma Committee.

M D Magri; A Veronesi; S Foladore; D De Giovanni; C Serra; F Crismancich; G Tuveri; M Nicotra; M Tommasi; S Morassut

doi:10.1177/030089169107700112

Epirubicin in the treatment of malignant mesothelioma: a phase II cooperative study. The North-Eastern Italian Oncology Group (GOCCNE)--Mesothelioma Committee.

Identifier:nobleid.org/w1/20260515/DA03633A

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DA03633A.svg?ark=w1%2F20260515%2FDA03633A)](https://nobleid.org/work/w1/20260515/DA03633A)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Epirubicin in the treatment of malignant mesothelioma: a phase II cooperative study. The North-Eastern Italian Oncology Group (GOCCNE)--Mesothelioma Committee.

Identifier:nobleid.org/w1/20260515/DA03633A

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DA03633A.svg?ark=w1%2F20260515%2FDA03633A)](https://nobleid.org/work/w1/20260515/DA03633A)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work